Skip to content
10-Q

Quarterly Report

Artiva Biotherapeutics, Inc. ARTV

0001193125-25-275872

← back to feed
Filed
Nov 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 31, 2025 24.54M sh
Shares Diluted Q3 2025 · Sep 30, 2025 24.48M sh
Shares Diluted Q3 2025 · Sep 30, 2025 24.4M sh
Shares Diluted Q3 2025 · Sep 30, 2024 18.9M sh
Shares Diluted Q3 2025 · Sep 30, 2024 6.88M sh
Capex Q3 2025 · Sep 30, 2025 $2.17M
Capex Q3 2025 · Sep 30, 2024 $578K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$62.03M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$40.38M
Short Term Investments Q3 2025 · Sep 30, 2025 $97.46M
Short Term Investments Q3 2025 · Dec 31, 2024 $145.19M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $25.51M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $40.24M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $55.88M
Stockholders Equity Q3 2025 · Sep 30, 2025 $129.22M
Stockholders Equity Q3 2025 · Jun 30, 2025 $149.04M
Stockholders Equity Q3 2025 · Mar 31, 2025 $168.78M
Stockholders Equity Q3 2025 · Dec 31, 2024 $186.64M
Stockholders Equity Q3 2025 · Sep 30, 2024 $201M
Stockholders Equity Q3 2025 · Jun 30, 2024 −$191.1M
Stockholders Equity Q3 2025 · Mar 31, 2024 −$174.67M
Stockholders Equity Q3 2025 · Dec 31, 2023 −$162.02M
Current Liabilities Q3 2025 · Sep 30, 2025 $11.12M
Current Liabilities Q3 2025 · Dec 31, 2024 $12.25M
Total Liabilities Q3 2025 · Sep 30, 2025 $19.64M
Total Liabilities Q3 2025 · Dec 31, 2024 $22.94M
Current Assets Q3 2025 · Sep 30, 2025 $129.52M
Current Assets Q3 2025 · Dec 31, 2024 $188.63M
Total Assets Q3 2025 · Sep 30, 2025 $148.86M
Total Assets Q3 2025 · Dec 31, 2024 $209.58M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.88
Eps Diluted Q3 2025 · Sep 30, 2025 −$2.59
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.92
Eps Diluted Q3 2025 · Sep 30, 2024 −$7.16
Eps Basic Q3 2025 · Sep 30, 2025 −$0.88
Eps Basic Q3 2025 · Sep 30, 2025 −$2.59
Eps Basic Q3 2025 · Sep 30, 2024 −$0.92
Eps Basic Q3 2025 · Sep 30, 2024 −$7.16
Sga Expense Q3 2025 · Sep 30, 2025 $5.26M
Sga Expense Q3 2025 · Sep 30, 2025 $15.33M
Sga Expense Q3 2025 · Sep 30, 2024 $4.81M
Sga Expense Q3 2025 · Sep 30, 2024 $12.26M
Rd Expense Q3 2025 · Sep 30, 2025 $17.63M
Rd Expense Q3 2025 · Sep 30, 2025 $52.55M
Rd Expense Q3 2025 · Sep 30, 2024 $13.52M
Rd Expense Q3 2025 · Sep 30, 2024 $37.01M
Net Income Q3 2025 · Sep 30, 2025 −$21.53M
Net Income Q3 2025 · Sep 30, 2025 −$63.09M
Net Income Q3 2025 · Jun 30, 2025 −$21.25M
Net Income Q3 2025 · Mar 31, 2025 −$20.31M
Net Income Q3 2025 · Sep 30, 2024 −$17.47M
Net Income Q3 2025 · Sep 30, 2024 −$49.28M
Net Income Q3 2025 · Jun 30, 2024 −$17.84M
Net Income Q3 2025 · Mar 31, 2024 −$13.96M
Operating Income Q3 2025 · Sep 30, 2025 −$22.9M
Operating Income Q3 2025 · Sep 30, 2025 −$67.88M
Operating Income Q3 2025 · Sep 30, 2024 −$18.34M
Operating Income Q3 2025 · Sep 30, 2024 −$49.02M